Your browser doesn't support javascript.
loading
CNS delivery of anti-CD52 antibodies modestly reduces disease severity in an animal model for multiple sclerosis.
Bogie, Jeroen Fj; Grajchen, Elien; Wouters, Elien; Broux, Bieke; Stinissen, Piet; Van Wijmeersch, Bart; Hendriks, Jerome Ja.
Affiliation
  • Bogie JF; Department of Immunology and Infection, Biomedical Research Institute, Hasselt University, Diepenbeek, Belgium.
  • Grajchen E; Department of Immunology and Infection, Biomedical Research Institute, Hasselt University, Diepenbeek, Belgium.
  • Wouters E; Department of Immunology and Infection, Biomedical Research Institute, Hasselt University, Diepenbeek, Belgium.
  • Broux B; Department of Immunology and Infection, Biomedical Research Institute, Hasselt University, Diepenbeek, Belgium.
  • Stinissen P; Department of Immunology and Infection, Biomedical Research Institute, Hasselt University, Diepenbeek, Belgium.
  • Van Wijmeersch B; Department of Immunology and Infection, Biomedical Research Institute, Hasselt University, Diepenbeek, Belgium.
  • Hendriks JJ; Department of Immunology and Infection, Biomedical Research Institute, Hasselt University, Agoralaan Building C, Diepenbeek, 3590, Belgium.
Ther Adv Chronic Dis ; 11: 2040622320947378, 2020.
Article in En | MEDLINE | ID: mdl-32913622
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Ther Adv Chronic Dis Year: 2020 Type: Article Affiliation country: Belgium
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Ther Adv Chronic Dis Year: 2020 Type: Article Affiliation country: Belgium